APA (7th ed.) Citation

R, G., H, L., Y, M., X, S., Y, H., Z, Z., & W, G. Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press.

Chicago Style (17th ed.) Citation

R, Guo, Liao H, Meng Y, Shi X, He Y, Zhu Z, and Guo W. Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press.

MLA (9th ed.) Citation

R, Guo, et al. Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press.